Systematic Evaluation of HLA-G 3’Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome

Despite major improvements in diagnostics and therapy in early as well as in locally advanced breast cancer (LABC), metastatic relapse occurs in about 20% of patients, often explained by early micro-metastatic spread into bone marrow by disseminated tumor cells (DTC). Although neoadjuvant chemothera...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Vera Rebmann, Esther Schwich, Rafael Tomoya Michita, Lisa Grüntkemeier, Ann-Kathrin Bittner, Hana Rohn, Peter A. Horn, Oliver Hoffmann, Rainer Kimmig, Sabine Kasimir-Bauer
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-01-01
Colecção:	Frontiers in Immunology
Assuntos:	HLA-G HLA-G UTR-4 breast cancer HLA-G 3’UTR polymorphism HLA-G UTR-2 HLA-G UTR-1
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.817132/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!